文献速递慢阻肺呼吸道感染

吸入糖皮质激素对慢阻肺患者痰细菌与病毒载量的长期影响

Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD.
PubMed 文献 · Eur Respir J · 2017-10-05

结果显示联合吸入糖皮质激素组痰细菌载量显著增加(p=0.005),且该增加仅见于基线痰或血嗜酸性粒细胞≤2%的患者。

要点

  • 长期吸入糖皮质激素可增加稳定期慢阻肺患者痰细菌载量。
  • 细菌载量增加仅见于基线嗜酸性粒细胞≤2%的患者。
  • 吸入糖皮质激素还改变痰微生物组成并增加潜在致病菌气道载量。

核心结论

  • 长期吸入糖皮质激素治疗影响稳定期慢阻肺患者的痰细菌载量。
  • 较低的嗜酸性粒细胞计数与气道细菌载量增加相关。

研究设计与样本

  • 患者随机接受沙美特罗50μg联合氟替卡松500μg或单用沙美特罗50μg,每日两次吸入,持续12个月。
  • 主要结局为治疗期间痰细菌载量的变化。

主要发现

  • 与单用沙美特罗相比,沙美特罗联合氟替卡松治疗1年与痰细菌载量显著增加相关(p=0.005)。
  • 联合治疗还伴随痰微生物组成的改变和潜在致病菌气道载量的增加。
  • 细菌载量增加仅见于基线痰或血嗜酸性粒细胞≤2%的吸入糖皮质激素治疗患者,基线嗜酸性粒细胞较高的患者中未见此现象。

临床怎么用

  • 对稳定期慢阻肺患者长期使用含吸入糖皮质激素方案时,应关注气道细菌载量增加的风险。
  • 基线嗜酸性粒细胞≤2%的患者可能从长期吸入糖皮质激素中获益较少且气道细菌负荷增加风险较高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Inhaled corticosteroid-containing medications reduce the frequency of COPD exacerbations (mainly infectious in origin) while paradoxically increasing the risk of other respiratory infections. The aim was to determine the effects of inhaled corticosteroids on airway microbial load in COPD patients and evaluate the influence of the underlying inflammatory profile on airway colonisation and microbiome.This is a proof-of-concept prospective, randomised, open-label, blinded endpoint study. Sixty patients with stable moderate COPD were randomised to receive one inhalation twice daily of either a combination of salmeterol 50 μg plus fluticasone propionate 500 μg or salmeterol 50 μg for 12 months. The primary outcome was the change of sputum bacterial loads over the course of treatment.Compared with salmeterol, 1-year treatment with salmeterol plus fluticasone was associated with a significant increase in sputum bacterial load (p=0.005), modification of sputum microbial composition and increased airway load of potentially pathogenic bacteria. The increased bacterial load was observed only in inhaled corticosteroid-treated patients with lower baseline sputum or blood eosinophil (≤2%) levels but not in patients with higher baseline eosinophils.Long-term inhaled corticosteroid treatment affects bacterial load in stable COPD. Lower eosinophil counts are associated with increased airway bacterial load.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Contoli M, Pauletti A, Rossi MR, et al. Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD. Eur Respir J. 2017. PMID: 28982774. doi:10.1183/13993003.00451-2017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。